Fundamental Valuation Report Pinnacle Finl Partners(PNFP:NAS) Financial Services:Banks – Regional This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$89.56 (USD) 03/30/2021 Weighted Valuation$92.05 (USD) Overall RatingFairly valued to slightly Undervalued by …

Pinnacle Finl Partners (PNFP:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report PPD(PPD:NAS) Healthcare:Drug Manufacturers – Specialty & Generic This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$37.71 (USD) 03/30/2021 Weighted Valuation$40.59 (USD) Overall RatingUndervalued by 7.6% Valuation Models …

PPD (PPD:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Park National(PRK:ASE) Financial Services:Banks – Regional This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$133.36 (USD) 03/30/2021 Weighted Valuation$126.29 (USD) Overall RatingOvervalued by 5.3% Valuation Models Adjusted …

Park National (PRK:ASE) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Palantir Technologies(PLTR:NYS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$22.04 (USD) 03/30/2021 Weighted Valuation$23.50 (USD) Overall RatingUndervalued by 6.6% Valuation Models Comparables: $34.15 (USD) …

Palantir Technologies (PLTR:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report New York Community(NYCB:NYS) Financial Services:Banks – Regional This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.67 (USD) 03/30/2021 Weighted Valuation$13.00 (USD) Overall RatingFairly valued to slightly Undervalued by …

New York Community (NYCB:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report New York Mortgage Trust(NYMT:NAS) Real Estate:REIT – Mortgage This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.52 (USD) 03/30/2021 Weighted Valuation$4.25 (USD) Overall RatingOvervalued by 5.9% Valuation …

New York Mortgage Trust (NYMT:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report ONE Gas(OGS:NYS) Utilities:Utilities – Regulated Gas This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$76.06 (USD) 03/30/2021 Weighted Valuation$80.00 (USD) Overall RatingUndervalued by 5.2% Valuation Models Adjusted …

ONE Gas (OGS:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Outfront Media(OUT:NYS) Real Estate:REIT – Specialty This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$21.74 (USD) 03/30/2021 Weighted Valuation$24.44 (USD) Overall RatingUndervalued by 12.4% Valuation Models Adjusted …

Outfront Media (OUT:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Occidental Petroleum(OXY:NYS) Energy:Oil & Gas E&P This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.33 (USD) 03/30/2021 Weighted Valuation$30.01 (USD) Overall RatingUndervalued by 9.8% Valuation Models Comparables: $29.23 …

Occidental Petroleum (OXY:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Pacific Biosciences(PACB:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$29.95 (USD) 03/30/2021 Weighted Valuation$29.15 (USD) Overall RatingFairly valued to slightly Overvalued by 2.7% Valuation …

Pacific Biosciences (PACB:NAS) Fundamental Valuation Report Read more »

Read More